N J L M

 
Subscribe Via RSS
  • Home
  • About
    Salient Features Bibliographic Information Abstracting and Indexing Specialties Covered Publisher Journal Policy
  • Issues
    Current Issue Online Ahead of Print Archive Forthcoming issue
  • Editorial
    Editorial Statements Editorial-PeerReview Process Editorial Board Publication Ethics & Malpractice Join us
  • Authors
    Submit an Article Manuscript Instructions Manuscript Assistance Publication Charges Paid Services Early Online Publication Service
  • Reviewers
    Apply as Reviewer Reviewers Acknowledgment
  • Search
    Simple Search Advanced Search
  • Member
    Register Login
  • Contact
  • Subscription
Original article / research
Year: 2023 Month: April Volume: 12 Issue: 2 Page: MO10 - MO13

Significance of Flu Vaccination against SARS-CoV-2 Infection: A Questionnaire-based Survey

 
Correspondence Rajeev Kishore Saxena, Anand Mohan Verma, Sana Nudrat, Soumya Pandey,
Dr. Sana Nudrat,
Demonstrator, Department of Microbiology, MDB Autonomous State Medical College, Deoria, Uttar Pradesh, India.
E-mail: nudratsana1@gmail.com
:
Introduction: Before the Coronavirus Disease 2019 (COVID-19) vaccines were developed, there was an intense search for preventive measures and effective treatments of COVID-19, which has led to a recommendation of influenza vaccination as a preventive measure against COVID-19. As of August 2022, there are still many countries where percentage of at least one dose of COVID-19 vaccination is ≤20%. In such a scenario it becomes pertinent for a continuous search of other preventive measures such as significance of flu vaccination against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection.

Aim: To explore any relation between the flu vaccination and SARS-CoV-2 infection.

Materials and Methods: A retrospective case-control study was undertaken through questionnaire-based survey with 200 cases who had taken flu vaccination within one year of COVID-19 testing and 800 as controls. All candidates were consecutively enrolled in this study and informed consent was obtained.

Results: Most common age group among vaccinated candidates was 31-40 years. Among 200 individuals of cases group, 3 (1.5%) were positive for COVID-19 and 197 (98.5%) were negative. Among 3 positive individuals in cases only one required hospitalisation. Among 800 control group, 38 (4.7%) were positive and 762 (95.2%) were negative for SARS-CoV-2 infection. Rate of positivity was 2.3% less among vaccinated group in comparison to non vaccinated group.

Conclusion: In this study it was observed that individuals who had received the flu vaccine there was a significant reduction in odds of testing positive for COVID-19 compared to those who did not received the vaccine.
 
[ FULL TEXT ]   |   [ ]
 
Print
  • Article Utilities

    • Readers Comments (0)
    • Article in PDF
    • Citation Manager
    • Article Statistics
    • Link to PUBMED
    • Print this Article
    • Send to a Friend
    • Go To Issues

      • Current Issue
      • Past Issues
  • Search Articles

    • Simple Search
    • Advance Search
  • Authors Facilities

    • Extensive Author Support
    • Submit Manuscript
    • ONLINE First Facility
    • NJLM Pre Publishing
  • Quick Links

    • REVIEWER
    • ACCESS STATISTICS
  • Users

    • Register
    • Log in
  • Pages

    • About
    • Issues
    • Editorials
    • Authors
    • Reviewers
    • Search
    • Contacts
  • Issues Archives

  • Affiliated Websites

    • JCDR Prepublishing
    • Neonatal Database Home
    • JCDR Neonatal Database download center